WTG Attendees include:

2010 Speakers included:
Dr. Eddie French
Director, Pharmaceutical Sciences
Pfizer Global R&D
& Chairman
Academy Pharmaceutical Sciences GB
17th - 18th January 2011
Maritim ProArte Hotel Berlin, Germany
It is a challenging time for the pharmaceutical industry with generic competition, price restrictions and the US healthcare reforms impacting on current and future revenues.
Companies are increasingly turning to their pharmaceutical development departments to get new drugs to market and extend the lifetime of existing products. With the global market for advanced delivery systems amounting to $134.3 billion in 2008, and estimated to reach $196.4 billion in 2014*, it is becoming increasingly evident that new technologies are critical for the future of the pharma industry.
Drug Delivery and Formulation will see over 200 industry professionals from across pharmaceutical and biologic formulation and drug delivery disciplines converge to discuss themes including:
- Formulation strategies for poorly soluble compounds
- Novel delivery methods for protein and peptide therapeutics
- Reformulation for product lifecycle extensions
- Advances in drug delivery devices and the impact on formulations
- Partnering and out-sourcing to support in-house formulation development
- The impact of product price restrictions on the investment in novel delivery technologies
Why should you attend?
Experience a range of conference sessions over two days with streams dedicated to biologic formulation, small molecule formulation and drug delivery partnerships.
Network with 200 + senior level professionals from disciplines including
|
|
| *Advanced Drug Delivery Systems: New Developments, New Technologies, BCC Research, August 2009 | |
Dr. René Holm
Dr. Thomas Keller
Ursula Redeker


